Journal Article Summary
The article investigates the potential of two antihistamines, loratadine (LOR) and desloratadine (DES), to inhibit the entry of the SARS-CoV-2 virus into human cells. This research is significant due to the urgent need for effective treatments for COVID-19, especially as developing new drugs or vaccines can take a long time. By exploring existing medications, the study aims to find quicker therapeutic options that could help manage the pandemic.
In this study, researchers conducted experiments using a pseudotyped virus that mimics SARS-CoV-2 to assess how well LOR and DES could prevent the virus from entering cells that overexpress the ACE2 receptor, which the virus uses to gain entry. The results showed that both antihistamines were effective, with DES demonstrating a significantly stronger inhibitory effect than LOR. The study also revealed that DES binds more effectively to the ACE2 receptor, which may explain its superior performance in blocking viral entry.
However, the study has limitations, including the use of pseudotyped viruses instead of live SARS-CoV-2, which may not fully represent how the virus behaves in real infections. Patients should be cautious and consult healthcare professionals before considering these antihistamines as a treatment for COVID-19, as further research is needed to confirm their effectiveness in clinical settings. Additionally, while LOR and DES have shown promise, their safety and efficacy in treating COVID-19 in humans remain to be established through further studies.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Hou Yajing, Ge Shuai, Li Xiaowei, Wang Cheng, He Huaizhen, He Langchong. Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis. Chemico-Biological Interactions 2021. DOI: 10.1016/j.cbi.2021.109420. PMID: 33609497. PMCID: PMC7889471.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
